Sign in
4

Changes in Ownership

NEKTAR THERAPEUTICS Filed Acc 0001209191-17-033770

SVP & Chief Operating Officer sold 3,146 shares at $19.55 ($61,504)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Nicholson John SVP & Chief Operating Officer 2017-05-16 Sale −3,146 $19.55 $61,504 178,943 D
Open-market sales · 3,146 sh · avg $19.55 · $61,504
Loading xslF345X03/doc4.xml…